{"id":513871,"date":"2021-07-15T16:33:07","date_gmt":"2021-07-15T20:33:07","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/clearpoint-neuro-inc-announces-appointment-of-lynnette-c-fallon-to-board-of-directors\/"},"modified":"2021-07-15T16:33:07","modified_gmt":"2021-07-15T20:33:07","slug":"clearpoint-neuro-inc-announces-appointment-of-lynnette-c-fallon-to-board-of-directors","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/clearpoint-neuro-inc-announces-appointment-of-lynnette-c-fallon-to-board-of-directors\/","title":{"rendered":"ClearPoint Neuro, Inc. Announces Appointment of Lynnette C. Fallon to Board of Directors"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">SOLANA BEACH, Calif., July  15, 2021  (GLOBE NEWSWIRE) &#8212; ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the \u201cCompany\u201d), a global therapy-enabling platform company providing navigation and delivery to the brain, is pleased to announce that Lynnette C. Fallon has been appointed to the Company\u2019s Board of Directors effective immediately. Ms. Fallon will also become a member of the Company\u2019s Audit Committee.<\/p>\n<p align=\"justify\">Ms. Fallon is the Executive Vice President, HR\/Legal, General Counsel and Secretary of Axcelis Technologies, Inc. (Nasdaq: ACLS), a provider of equipment and service solutions for the semiconductor manufacturing industry, with locations in eight countries. Ms. Fallon has held her current position since May 2005, having initially joined Axcelis in 2001 as a Senior Vice President and General Counsel. As a member of Axcelis\u2019 executive team for more than 20 years, Ms. Fallon has been involved with business development, financial and tax management, investor relations, diversity and inclusion initiatives, corporate social responsibility policies and other ESG matters, M&amp;A, risk management, and all aspects of international corporate compliance. She holds a J.D., <em>cum laude<\/em>, from the School of Law at Boston University and a B.A. with departmental and general honors, <em>Phi Beta Kappa<\/em>, from Vassar College.<\/p>\n<p align=\"justify\">\u201cWe are thrilled to have Lynnette join the ClearPoint Board and to begin her contributions immediately,\u201d commented Joe Burnett, President and CEO at ClearPoint Neuro. \u201cLynnette\u2019s role will benefit our growing company in many different and crucial facets, including human resources, M&amp;A, legal, and investor relations. We are all looking forward to getting started.\u201d<\/p>\n<p align=\"justify\">\u201cI am honored to join the ClearPoint Neuro Board,\u201d stated Lynnette Fallon. \u201cThe Company is at an exciting juncture, and I hope to use my skills and experience to contribute to its continuing success.\u201d<\/p>\n<p align=\"justify\">\n        <strong><br \/>\n          <u>About ClearPoint Neuro<\/u><br \/>\n        <\/strong>\n      <\/p>\n<p align=\"justify\">ClearPoint Neuro\u2019s mission is to improve and restore quality of life to patients and their families by enabling therapies for the most complex neurological disorders with pinpoint accuracy. Applications of the Company\u2019s current product portfolio include deep brain stimulation, laser ablation, biopsy, neuro-aspiration, and delivery of drugs, biologics, and gene therapy to the brain. The ClearPoint Neuro Navigation System has FDA clearance, is CE-marked, and is installed in over 60 active sites in the United States, Canada, and Europe. ClearPoint Neuro is partnered with over 30\u00a0biologics\/pharmaceutical companies and academic centers, providing solutions for direct CNS delivery of therapeutics in pre-clinical studies and clinical trials worldwide. To date, more than 4,500 cases have been performed and supported by the Company\u2019s field-based clinical specialist team, which offers support and services to our customers and partners. For more information, please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=phocVPnNefDA-LkXvLg7U_vawvcqcwyFd-rgaBpoXEn31embdzZKZrqrvo3QejNiG_IDVW_prb_Xr38CEtkP27FGjcp8yChdG-dEacwpt0Q=\" rel=\"nofollow noopener\" target=\"_blank\"><u>www.clearpointneuro.com<\/u><\/a>.<\/p>\n<p align=\"justify\">\n        <strong><br \/>\n          <u>Forward-Looking Statements<\/u><br \/>\n        <\/strong>\n      <\/p>\n<p align=\"justify\">Statements herein concerning the Company\u2019s plans, growth and strategies may include forward-looking statements within the context of the federal securities laws. Statements regarding the Company&#8217;s future events, developments and future performance, as well as management&#8217;s expectations, beliefs, plans, estimates or projections relating to the future, are forward-looking statements within the meaning of these laws. Uncertainties and risks may cause the Company&#8217;s actual results to differ materially from those expressed in or implied by forward-looking statements. Particular uncertainties and risks include those relating to: the impact of COVID-19 and the measures adopted to contain its spread; future revenues from sales of the Company\u2019s ClearPoint Neuro Navigation System products; and the Company\u2019s ability to market, commercialize and achieve broader market acceptance for the Company\u2019s ClearPoint Neuro Navigation System products. More detailed information on these and additional factors that could affect the Company\u2019s actual results are described in the \u201cRisk Factors\u201d section in the Company\u2019s Annual Report on Form 10-K for the year ended December 31, 2020, and the Company\u2019s Quarterly Report on Form 10-Q for the three months ended March 31, 2021, both of which have been filed with the Securities and Exchange Commission.<\/p>\n<p>      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI4MTQ2NiM0Mjk5OTg4IzIwMjcxMjA=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/d5fd83d1-44dc-4c72-bac5-ba96bc71c892\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\">\n<pre>Contact:\r\n\r\nJacqueline Keller, Vice President, Marketing\r\n1 (888) 287-9109\r\ninfo@clearpointneuro.com\r\n\r\nCaroline Corner, Investor Relations\r\nir@clearpointneuro.com<\/pre>\n<\/p><\/div>\n","protected":false},"excerpt":{"rendered":"<p>SOLANA BEACH, Calif., July 15, 2021 (GLOBE NEWSWIRE) &#8212; ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the \u201cCompany\u201d), a global therapy-enabling platform company providing navigation and delivery to the brain, is pleased to announce that Lynnette C. Fallon has been appointed to the Company\u2019s Board of Directors effective immediately. Ms. Fallon will also become a member of the Company\u2019s Audit Committee. Ms. Fallon is the Executive Vice President, HR\/Legal, General Counsel and Secretary of Axcelis Technologies, Inc. (Nasdaq: ACLS), a provider of equipment and service solutions for the semiconductor manufacturing industry, with locations in eight countries. Ms. Fallon has held her current position since May 2005, having initially joined Axcelis in 2001 as a Senior Vice President and General Counsel. As a &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/clearpoint-neuro-inc-announces-appointment-of-lynnette-c-fallon-to-board-of-directors\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;ClearPoint Neuro, Inc. Announces Appointment of Lynnette C. Fallon to Board of Directors&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-513871","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>ClearPoint Neuro, Inc. Announces Appointment of Lynnette C. Fallon to Board of Directors - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/clearpoint-neuro-inc-announces-appointment-of-lynnette-c-fallon-to-board-of-directors\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ClearPoint Neuro, Inc. Announces Appointment of Lynnette C. Fallon to Board of Directors - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"SOLANA BEACH, Calif., July 15, 2021 (GLOBE NEWSWIRE) &#8212; ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the \u201cCompany\u201d), a global therapy-enabling platform company providing navigation and delivery to the brain, is pleased to announce that Lynnette C. Fallon has been appointed to the Company\u2019s Board of Directors effective immediately. Ms. Fallon will also become a member of the Company\u2019s Audit Committee. Ms. Fallon is the Executive Vice President, HR\/Legal, General Counsel and Secretary of Axcelis Technologies, Inc. (Nasdaq: ACLS), a provider of equipment and service solutions for the semiconductor manufacturing industry, with locations in eight countries. Ms. Fallon has held her current position since May 2005, having initially joined Axcelis in 2001 as a Senior Vice President and General Counsel. As a &hellip; Continue reading &quot;ClearPoint Neuro, Inc. Announces Appointment of Lynnette C. Fallon to Board of Directors&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/clearpoint-neuro-inc-announces-appointment-of-lynnette-c-fallon-to-board-of-directors\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-07-15T20:33:07+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI4MTQ2NiM0Mjk5OTg4IzIwMjcxMjA=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/clearpoint-neuro-inc-announces-appointment-of-lynnette-c-fallon-to-board-of-directors\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/clearpoint-neuro-inc-announces-appointment-of-lynnette-c-fallon-to-board-of-directors\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"ClearPoint Neuro, Inc. Announces Appointment of Lynnette C. Fallon to Board of Directors\",\"datePublished\":\"2021-07-15T20:33:07+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/clearpoint-neuro-inc-announces-appointment-of-lynnette-c-fallon-to-board-of-directors\\\/\"},\"wordCount\":643,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/clearpoint-neuro-inc-announces-appointment-of-lynnette-c-fallon-to-board-of-directors\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI4MTQ2NiM0Mjk5OTg4IzIwMjcxMjA=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/clearpoint-neuro-inc-announces-appointment-of-lynnette-c-fallon-to-board-of-directors\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/clearpoint-neuro-inc-announces-appointment-of-lynnette-c-fallon-to-board-of-directors\\\/\",\"name\":\"ClearPoint Neuro, Inc. Announces Appointment of Lynnette C. Fallon to Board of Directors - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/clearpoint-neuro-inc-announces-appointment-of-lynnette-c-fallon-to-board-of-directors\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/clearpoint-neuro-inc-announces-appointment-of-lynnette-c-fallon-to-board-of-directors\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI4MTQ2NiM0Mjk5OTg4IzIwMjcxMjA=\",\"datePublished\":\"2021-07-15T20:33:07+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/clearpoint-neuro-inc-announces-appointment-of-lynnette-c-fallon-to-board-of-directors\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/clearpoint-neuro-inc-announces-appointment-of-lynnette-c-fallon-to-board-of-directors\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/clearpoint-neuro-inc-announces-appointment-of-lynnette-c-fallon-to-board-of-directors\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI4MTQ2NiM0Mjk5OTg4IzIwMjcxMjA=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI4MTQ2NiM0Mjk5OTg4IzIwMjcxMjA=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/clearpoint-neuro-inc-announces-appointment-of-lynnette-c-fallon-to-board-of-directors\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ClearPoint Neuro, Inc. Announces Appointment of Lynnette C. Fallon to Board of Directors\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ClearPoint Neuro, Inc. Announces Appointment of Lynnette C. Fallon to Board of Directors - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/clearpoint-neuro-inc-announces-appointment-of-lynnette-c-fallon-to-board-of-directors\/","og_locale":"en_US","og_type":"article","og_title":"ClearPoint Neuro, Inc. Announces Appointment of Lynnette C. Fallon to Board of Directors - Market Newsdesk","og_description":"SOLANA BEACH, Calif., July 15, 2021 (GLOBE NEWSWIRE) &#8212; ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the \u201cCompany\u201d), a global therapy-enabling platform company providing navigation and delivery to the brain, is pleased to announce that Lynnette C. Fallon has been appointed to the Company\u2019s Board of Directors effective immediately. Ms. Fallon will also become a member of the Company\u2019s Audit Committee. Ms. Fallon is the Executive Vice President, HR\/Legal, General Counsel and Secretary of Axcelis Technologies, Inc. (Nasdaq: ACLS), a provider of equipment and service solutions for the semiconductor manufacturing industry, with locations in eight countries. Ms. Fallon has held her current position since May 2005, having initially joined Axcelis in 2001 as a Senior Vice President and General Counsel. As a &hellip; Continue reading \"ClearPoint Neuro, Inc. Announces Appointment of Lynnette C. Fallon to Board of Directors\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/clearpoint-neuro-inc-announces-appointment-of-lynnette-c-fallon-to-board-of-directors\/","og_site_name":"Market Newsdesk","article_published_time":"2021-07-15T20:33:07+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI4MTQ2NiM0Mjk5OTg4IzIwMjcxMjA=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/clearpoint-neuro-inc-announces-appointment-of-lynnette-c-fallon-to-board-of-directors\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/clearpoint-neuro-inc-announces-appointment-of-lynnette-c-fallon-to-board-of-directors\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"ClearPoint Neuro, Inc. Announces Appointment of Lynnette C. Fallon to Board of Directors","datePublished":"2021-07-15T20:33:07+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/clearpoint-neuro-inc-announces-appointment-of-lynnette-c-fallon-to-board-of-directors\/"},"wordCount":643,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/clearpoint-neuro-inc-announces-appointment-of-lynnette-c-fallon-to-board-of-directors\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI4MTQ2NiM0Mjk5OTg4IzIwMjcxMjA=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/clearpoint-neuro-inc-announces-appointment-of-lynnette-c-fallon-to-board-of-directors\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/clearpoint-neuro-inc-announces-appointment-of-lynnette-c-fallon-to-board-of-directors\/","name":"ClearPoint Neuro, Inc. Announces Appointment of Lynnette C. Fallon to Board of Directors - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/clearpoint-neuro-inc-announces-appointment-of-lynnette-c-fallon-to-board-of-directors\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/clearpoint-neuro-inc-announces-appointment-of-lynnette-c-fallon-to-board-of-directors\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI4MTQ2NiM0Mjk5OTg4IzIwMjcxMjA=","datePublished":"2021-07-15T20:33:07+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/clearpoint-neuro-inc-announces-appointment-of-lynnette-c-fallon-to-board-of-directors\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/clearpoint-neuro-inc-announces-appointment-of-lynnette-c-fallon-to-board-of-directors\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/clearpoint-neuro-inc-announces-appointment-of-lynnette-c-fallon-to-board-of-directors\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI4MTQ2NiM0Mjk5OTg4IzIwMjcxMjA=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI4MTQ2NiM0Mjk5OTg4IzIwMjcxMjA="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/clearpoint-neuro-inc-announces-appointment-of-lynnette-c-fallon-to-board-of-directors\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"ClearPoint Neuro, Inc. Announces Appointment of Lynnette C. Fallon to Board of Directors"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/513871","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=513871"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/513871\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=513871"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=513871"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=513871"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}